Skip to main content
. 2016 Aug;107(2):106–115. doi: 10.5935/abc.20160095

Table 2.

Medications administered within 24 hours and at hospital discharge to all patients with acute coronary syndrome and to those in each subgroup, excluding prehospital deaths (n = 583)

Medication All patients STEMI NSTEMI Unstable angina
24 hours n = 583 n = 204 n = 73 n = 306
    Aspirin 563 (96.6) 194 (95.1) 69 (94.5) 300 (98.0)
    P2Y12 inhibitors 501 (85.9) 181 (88.7) 65 (89.0) 255 (83.3)
    Heparins* 372 (63.8) 155 (73.1) 58 (79.5) 160 (52.3)
    Beta-blockers 402 (69.0) 139 (68.1) 52 (71.2) 211 (69.0)
    Statins 474 (81.3) 168 (82.4) 59 (80.8) 247 (80.7)
    ACEI or ARB 391 (67.1) 131 (64.2) 45 (61.6) 215 (70.3)
Discharge n = 528 n = 169 n = 68 n = 291
    Aspirin 492 (93.2) 158 (93.5) 64 (94.1) 270 (92.8)
    P2Y12 inhibitors 362 (68.6) 127 (75.1) 46 (67.6) 183 (62.9)
    Beta-blockers 411 (77.8) 136 (80.5) 56 (82.4) 219 (75.5)
    Statins 452 (85.6) 149 (88.2) 62 (91.2) 241 (82.8)
    ACEI or ARB 337 (63.8) 109 (64.5) 42 (61.8) 186 (63.9)
*

Unfractioned heparin or low-molecular-weight heparin. STEMI: ST-elevation myocardial infarction; NSTEMI: non-ST-elevation myocardial infarction; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker II. †Excluding patients who died.

Excluding patients who died.